BioCentury | Dec 6, 2019
Preclinical News

Dec. 5 Preclinical Quick Takes: Simpler synthesis of Merck’s HIV therapy; plus MRSA antibiotic, once-monthly oral contraceptive

...R (GraR) inhibitor that resensitized methicillin-resistant Staphylococcus aureus (MRSA) to methicillin and raised sensitivity to cefuroxime...
BioCentury | Sep 25, 2019
Politics & Policy

Additional price cuts in nationwide expansion of China’s centralized procurement

...company announced it won bids for epilepsy and seizure drug levetiracetam and the cephalosporin antibiotic cefuroxime...
BioCentury | Jan 2, 2012
Company News

Covis, GlaxoSmithKline sales and marketing update

...GlaxoSmithKline granted Covis U.S. and Puerto Rican rights to commercialize antibiotics Fortaz ceftazidime and Zinacef cefuroxime...
...Fortaz injection, Zinacef injection, Parnate and Zantac injection, while Lanoxin tablets and injection, Fortaz frozen, Zinacef...
BioCentury | Oct 30, 2006
Regulation

The ABS comparisons

...80.3% (237/295) -0.9 70.8% (262/370) -3.2 Faropenem 10 days 81.8% (229/280) 0.5 69.9% (255/365) -4.2 Cefuroxime...
...246/300) NA 76.0% (269/354) NA 10186 Faropenem 7 days 89.0% (203/228) -5.2 86.2% (237/275) -7.0 Cefuroxime...
BioCentury | Oct 30, 2006
Regulation

On the market

...Product Class Amoxil amoxicillin (GlaxoSmithKline) Beta-lactam Augmentin amoxicillin/clavulanate (GlaxoSmithKline) Beta-lactam Omnicef cefdinir (Abbott) Beta-lactam Ceftin cefuroxime...
BioCentury | Oct 30, 2006
Regulation

Up next

...Broad spectrum ABS Dec. 15 PDUFA date Non-inferiority to comparators, including Oscient gemifloxacin fluoroquinolone antibiotic cefuroxime...
...prodrug derivative of faropenem ABS; AECB; CAP; and SSSI Not approvable Non-inferiority to comparators, including cefuroxime...
BioCentury | Oct 30, 2006
Regulation

Antibiotic resistance

...one of the three Phase III non-inferiority trials also showed that faropenem was superior to cefuroxime...
BioCentury | Sep 18, 2006
Product Development

Non-inferiority in ABS

...supporting approval Timing of measurements Status Beta Lactam Replidyne/Forest Orapem (Faropenem) medoxomil Non-inferiority comparison w/ cefuroxime...
...visit (day 28) Approved 2004 Ketolide sanofi-aventis Group Ketek telithromycin Non-inferiority comparision with amoxicillin/clavulanic and cefuroxime...
...visit (days 17-24) Approved 2004 Quinolone Oscient/LG Life Sciences Factive gemifloxacin mesylate Non-inferiority comparisons w/ cefuroxime...
BioCentury | Jun 12, 2006
Clinical News

Ketek telithromycin: Phase III suspended enrollment

...aged 6 months to 5 years to treat acute otitis media is comparing telithromycin to cefuroxime...
BioCentury | Oct 17, 2005
Clinical News

Factive gemifloxacin mesylate: Phase III data

...asthma and sinusitis patients, but not chronic bronchitis patients. Comparators included clarithromycin, levofloxacin, trovafloxacin, amoxicillin/clavulanate, ceftriaxone/cefuroxime...
Items per page:
1 - 10 of 14